E Höfler

470 total citations
10 papers, 368 citations indexed

About

E Höfler is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, E Höfler has authored 10 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 4 papers in Immunology and 2 papers in Oncology. Recurrent topics in E Höfler's work include Systemic Lupus Erythematosus Research (4 papers), T-cell and B-cell Immunology (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). E Höfler is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), T-cell and B-cell Immunology (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). E Höfler collaborates with scholars based in Austria, Germany and United States. E Höfler's co-authors include G Steiner, Josef S Smolen, W. Graninger, Martin Aringer, Georg Stummvoll, C. W. Steiner, Carl W. Steiner, A Studnicka-Benke, Marcus Köller and Eva Feierl and has published in prestigious journals such as Lara D. Veeken, Arthritis Research & Therapy and Lupus.

In The Last Decade

E Höfler

8 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Höfler Austria 6 252 226 75 61 48 10 368
Alicia Eimon Argentina 9 186 0.7× 170 0.8× 70 0.9× 44 0.7× 51 1.1× 14 317
Francesca Miranda Italy 11 213 0.8× 140 0.6× 56 0.7× 20 0.3× 63 1.3× 19 323
Franziska Szelinski Germany 11 169 0.7× 242 1.1× 44 0.6× 58 1.0× 69 1.4× 22 384
Alice Lorenzi United Kingdom 8 124 0.5× 143 0.6× 36 0.5× 31 0.5× 28 0.6× 12 272
TRDJ Radstake Netherlands 10 118 0.5× 97 0.4× 34 0.5× 52 0.9× 43 0.9× 20 268
Natalie Sippl Sweden 6 159 0.6× 176 0.8× 96 1.3× 28 0.5× 33 0.7× 11 274
Lucyna Korman Poland 12 213 0.8× 163 0.7× 29 0.4× 64 1.0× 48 1.0× 27 404
Souichiro Nakano Japan 9 126 0.5× 229 1.0× 25 0.3× 38 0.6× 34 0.7× 21 322
John B. Harley United States 6 253 1.0× 256 1.1× 92 1.2× 45 0.7× 61 1.3× 7 395
Lidia Ostanek Poland 9 154 0.6× 139 0.6× 31 0.4× 28 0.5× 47 1.0× 39 296

Countries citing papers authored by E Höfler

Since Specialization
Citations

This map shows the geographic impact of E Höfler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Höfler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Höfler more than expected).

Fields of papers citing papers by E Höfler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Höfler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Höfler. The network helps show where E Höfler may publish in the future.

Co-authorship network of co-authors of E Höfler

This figure shows the co-authorship network connecting the top 25 collaborators of E Höfler. A scholar is included among the top collaborators of E Höfler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Höfler. E Höfler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Höfler, E, et al.. (2018). Praktische Diätetik.
2.
Höfler, E, et al.. (2013). Praktische Diätetik. Deutsche Zeitschrift für Akupunktur. 56(3). 49–49.
3.
Skriner, Karl, Wolfgang Hueber, E Höfler, et al.. (2008). AUF1, the regulator of tumor necrosis factor α messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. Arthritis & Rheumatism. 58(2). 511–520. 18 indexed citations
4.
Aringer, Martin, G Steiner, W. Graninger, et al.. (2006). Effects of short‐term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis & Rheumatism. 56(1). 274–279. 84 indexed citations
5.
Aringer, Martin, et al.. (2003). Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE). Arthritis Research. 5(Suppl 1). 33–33. 1 indexed citations
6.
Aringer, Martin, Eva Feierl, G Steiner, et al.. (2002). Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death. Lupus. 11(2). 102–108. 90 indexed citations
7.
Aringer, Martin, Georg Stummvoll, G Steiner, et al.. (2001). Serum interleukin‐15 is elevated in systemic lupus erythematosus. Lara D. Veeken. 40(8). 876–881. 92 indexed citations
8.
Zimmermann, Christof, et al.. (2001). Analysis of anti-Ro52 antibodies in sera of healthy subjects. Arthritis Research & Therapy. 3(S2). 1 indexed citations
9.
Zimmermann, Christof, Josef S Smolen, W. Graninger, et al.. (1996). Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.. PubMed. 23(11). 1897–903. 23 indexed citations
10.
Steiner, G, et al.. (1995). Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.. PubMed. 22(3). 406–12. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026